Print

VAX 004

Trial Details:

III Completed
VaxGen June 01, 1998
AIDSVAX B/B gp120 HIV-1 envelope antigens (300 ?g each of MN and GNE8 rgp120/HIV-1)
AIDSVAX B/B Protein
Canada, Netherlands, Puerto Rico, USA 5,400
NCT00002441
https://www.clinicaltrials.gov/ct2/show/NCT00002441